Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Journey Medical Stock Price, Quotes and Forecasts | NASDAQ:DERM | Benzinga

Q: What sector and industry does Journey Medical (DERM) operate in?

Journey Medical is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.

Explore Journey Medical stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for DERM.

Open	-
Close	-
Volume / Avg.	0 / 59.16K
Day Range	- - -
52 Wk Range	2.85 - 6.89
Market Cap	$120.74M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	74
Short Interest	2.53%
Days to Cover	2.46

Recent News

What's Going On With Journey Medical Stock Today?

Journey Medical (NASDAQ:DERM) shares are trading higher Monday after the company announced the U.S. Food and Drug Administration approved its Emrosi drug for the treatment of rosacea.

Adam Eckert

Why Skye Bioscience Shares Are Trading Lower By 19%? Here Are Other Stocks Moving In Monday's Mid-Day Session

Avi Kapoor

Journey Medical And 2 Other Stocks Under $4 Insiders Are Buying

The Dow Jones index closed higher by over 475 points on Wednesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Rating and Forecast

4.0

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	-
Close	-
Volume / Avg.	0 / 59.16K
Day Range	- - -
52 Wk Range	2.85 - 6.89
Market Cap	$120.74M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	74
Short Interest	2.53%
Days to Cover	2.46

About Journey Medical Corp

Sector

Health Care

Industry

Pharmaceuticals

Journey Medical Corp is a commercial stage pharmaceutical company focused on the development and com...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Journey Medical (DERM) stock?

You can purchase shares of Journey Medical (NASDAQ:DERM) through any online brokerage.

View our list of the best stock brokerages

Who are Journey Medical (DERM) competitors?

Other companies in Journey Medical’s space includes: Atea Pharmaceuticals (NASDAQ:AVIR), Third Harmonic Bio (NASDAQ:THRD), Bioage Labs (NASDAQ:BIOA), Neumora Therapeutics (NASDAQ:NMRA) and Aardvark Therapeutics (NASDAQ:AARD).

What is the forecast, or price target, for Journey Medical (DERM) stock?

Journey Medical has a consensus price target of $8.70.

What is the current price for Journey Medical (DERM)?

The stock price for Journey Medical (NASDAQ: DERM) is $5.78 last updated March 24, 2025 at 9:29 AM EDT.

Does Journey Medical (DERM) pay a dividend?

There are no upcoming dividends for Journey Medical.

When is Journey Medical (NASDAQ:DERM) reporting earnings?

Journey Medical’s Q1 earnings are confirmed for Monday, May 12, 2025.

Is Journey Medical (DERM) going to split?

There is no upcoming split for Journey Medical.

What sector and industry does Journey Medical (DERM) operate in?

Journey Medical is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.

Comments

Journey Medical Stock Price, Quotes and Forecasts

Journey Medical (DERM) Forecast